A detailed history of Goodman Advisory Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Goodman Advisory Group, LLC holds 19,201 shares of AZN stock, worth $1.21 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
19,201
Previous 19,484 1.45%
Holding current value
$1.21 Million
Previous $1.52 Million 1.51%
% of portfolio
0.43%
Previous 0.45%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$76.67 - $87.62 $21,697 - $24,796
-283 Reduced 1.45%
19,201 $1.5 Million
Q2 2024

Aug 15, 2024

BUY
$66.81 - $80.83 $1.3 Million - $1.57 Million
19,484 New
19,484 $1.52 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $196B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Goodman Advisory Group, LLC Portfolio

Follow Goodman Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goodman Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Goodman Advisory Group, LLC with notifications on news.